Evidence map›Paper›PMID 39291011›Full record

ArticleACS medicinal chemistry letters2024

Highly Selective Novel Heme Oxygenase-1 Hits Found by DNA-Encoded Library Machine Learning beyond the DEL Chemical Space.

Shuai Han, Xinyun Guo, Min Wang, Huan Liu, Yidan Song, Yunyun He, Kuang-Lung Hsueh, Weiren Cui, Wenji Su, Letian Kuai and 1 more

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shuai HanWuXi AppTec (Shanghai) Co., Ltd., 240 Hedan Road, Shanghai 200131, China.ORCID https://orcid.org/0009-0001-0137-5651
Xinyun GuoWuXi AppTec (Shanghai) Co., Ltd., 240 Hedan Road, Shanghai 200131, China.
Min WangWuXi AppTec (Shanghai) Co., Ltd., 240 Hedan Road, Shanghai 200131, China.
Huan LiuWuXi AppTec (Shanghai) Co., Ltd., 240 Hedan Road, Shanghai 200131, China.
Yidan SongWuXi AppTec (Shanghai) Co., Ltd., 240 Hedan Road, Shanghai 200131, China.
Yunyun HeWuXi AppTec (Shanghai) Co., Ltd., 240 Hedan Road, Shanghai 200131, China.
Kuang-Lung HsuehWuXi AppTec (Shanghai) Co., Ltd., 240 Hedan Road, Shanghai 200131, China.
Weiren CuiWuXi AppTec (Shanghai) Co., Ltd., 240 Hedan Road, Shanghai 200131, China.
Wenji SuWuXi AppTec (Shanghai) Co., Ltd., 240 Hedan Road, Shanghai 200131, China.ORCID https://orcid.org/0000-0003-1093-167X
Letian KuaiWuXi AppTec, 22 Strathmore Road, Natick, Massachusetts 01760, United States.
Jason DengWuXi AppTec, 22 Strathmore Road, Natick, Massachusetts 01760, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA-encoded library (DEL) technology, especially when combined with machine learning (ML), is a powerful method to discover novel inhibitors. DEL-ML can expand a larger chemical space and boost cost-effectiveness during hit finding. Heme oxygenase-1 (HO-1), a heme-degrading enzyme, is linked to diseases such as cancer and neurodegenerative disorders. The discovery of five series of new scaffold HO-1 hits is reported here, using a DEL-ML workflow, which emphasizes the model's uncertainty quantification and domain of applicability. This model exhibits a strong extrapolation ability, identifying new structures beyond the DEL chemical space. About 37% of predicted molecules showed a binding affinity of

Identifiers

PMID39291011
PMCPMC11403747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.